September 28, 2026Stocks·Bullish·biotech
BioAge Labs says oral NLRP3 inhibition reversed age-related declines in aged mice
BioAge Labs said oral NLRP3 inhibition reversed age-related declines in motility, metabolism and social behavior in aged mice, with data presented at Cold Spring Harbor's Mechanisms of Aging meeting pointing to NLRP3 as a potential target for age-related disorders.
Detected & updated continuously · Source: Nebula
Story subjects
BioAge Labs, Inc.NLRP3